Opthea Ltd

UKJ

Company Profile

  • Business description

    Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.

  • Contact

    650 Chapel Street
    Level 4, Suite 0403
    South YarraVIC3141
    AUS

    T: +61 398260399

    https://www.opthea.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2025

    Employees

    34

Stocks News & Analysis

stocks

The surge in price of ASX listed share price is unwarranted

Good news as a proposed merger is approved but investors may be too optimistic. 
stocks

11 ASX dividend stocks for the next decade

What are the best stocks to own that can pay regular dividends and beat indices on a total return basis in the long-term? Here is our list of 11 ASX-listed companies that could help investors achieve these goals.
stocks

10 defensive ASX stocks to own in an expensive market

These shares may protect an investor in a volatile market. 

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,552.6071.000.84%
CAC 407,338.6786.93-1.17%
DAX 4019,215.48147.04-0.76%
Dow JONES (US)43,988.99259.650.59%
FTSE 1008,072.3968.35-0.84%
HKSE20,728.19225.15-1.07%
NASDAQ19,286.7817.320.09%
Nikkei 22539,500.37118.960.30%
NZX 50 Index12,770.33188.951.50%
S&P 5005,995.5422.440.38%
S&P/ASX 2008,295.1068.800.84%
SSE Composite Index3,452.3018.36-0.53%

Market Movers